Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

UDR, Inc. Prospectus 2007

Feb 23, 2007

30426_prs_2007-02-23_eb84bf32-a5dd-4983-8aed-19cf8827c588.zip

Prospectus

Open in viewer

Opens in your device viewer

424B7 1 a07-5310_1424b7.htm 424B7

*Filed Pursuant to Rule 424(b)(7) Registration No. 333-139904*

*Prospectus Supplement No. 2* (To Prospectus dated January 10, 2007, as supplemented by Prospectus Supplement No. 1 dated February 2, 2007)

*United Dominion Realty Trust, Inc.*

*$250,000,000 Principal Amount of 3.625% Convertible Senior Notes due 2011 and Shares of Common Stock Issuable Upon Conversion of the Notes*

This prospectus supplement supplements information contained in that certain prospectus dated January 10, 2007 of United Dominion Realty Trust, Inc., as supplemented by Prospectus Supplement No. 1 dated February 2, 2007, which we collectively refer to as the “prospectus,” covering resales by selling securityholders identified therein of our 3.625% convertible senior notes due 2011 and shares of our common stock into which the notes are convertible.

You should read this prospectus supplement in conjunction with the prospectus. This prospectus supplement updates information in the “Selling Securityholders” section of the prospectus and, accordingly, to the extent inconsistent, the information in this prospectus supplement supersedes the information contained in the prospectus, as amended and supplemented. This prospectus supplement may not be delivered or utilized without the prospectus. This prospectus supplement is qualified by reference to the prospectus, except to the extent that the information in this prospectus supplement supersedes the information contained in the prospectus.

*To read about certain factors you should consider before investing in the notes and our common stock, see “Risk Factors” beginning on page 5 of the prospectus dated January 10, 2007.*

*Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus supplement or the prospectus. Any representation to the contrary is a criminal offense.*

The date of this Prospectus Supplement is February 23, 2007.

SEQ.=1,FOLIO='',FILE='C:\fc\5312363682_D10496_1748722\5310-1-be.htm',USER='jmsproofassembler',CD='Feb 22 12:36 2007'

The information appearing under the section entitled “Selling Securityholders” on pages 72 through 75 of the prospectus dated January 10, 2007 is amended and restated in its entirety by the information below.

SELLING SECURITYHOLDERS

We originally issued the notes to J.P. Morgan Securities Inc., Merrill Lynch, Pierce Fenner & Smith Incorporated, Wachovia Capital Markets, LLC and Bear, Stearns & Co. Inc. in a private placement on October 12, 2006. The notes were immediately resold by the initial purchasers to persons reasonably believed by the initial purchasers to be qualified institutional buyers within the meaning of Rule 144A under the Securities Act in transactions exempt from registration under the Securities Act. Selling securityholders, including their transferees, pledgees or donees or their successors, may from time to time offer and sell the notes and our common stock issuable upon conversion of the notes pursuant to this prospectus. Unless set forth below, none of the selling securityholders has had within the past three years any material relationship with us or any of our predecessors or affiliates.

The following table sets forth certain information concerning the principal amount of notes beneficially owned by each selling securityholder and the number of shares of common stock that may be offered from time to time by each selling securityholder under this prospectus. The information is based on information provided to us by or on behalf of the selling securityholders on or prior to February 22, 2007.

Because the selling securityholders may offer all, some or none of the notes or common stock issuable upon conversion of the notes, we have assumed for purposes of the table below that the named selling securityholders will sell all of the notes or common stock issuable upon conversion of the notes. In addition, the selling securityholders identified below may have sold, transferred or otherwise disposed of all or a portion of their notes since the date on which they provided the information regarding their notes in transactions exempt from the registration requirements of the Securities Act. Unless otherwise indicated below, to our knowledge no selling securityholder named in the table below beneficially owns one percent or more of our common stock, assuming conversion of such selling securityholder’s notes.

To our knowledge, except as described below, the selling securityholders have sole voting and investment power with respect to all of the securities shown as beneficially owned by them .

2

SEQ.=1,FOLIO='2',FILE='C:\fc\5312363682_D10496_1748722\5310-1-be.htm',USER='jmsproofassembler',CD='Feb 22 12:36 2007'

Name Principal Amount of Notes Beneficially Owned and Offered Hereby (1) Percentage of Notes Outstanding Common Stock Offered Hereby(2) Percentage of Common Stock Outstanding (3)
ADI Alternative
Investments $ 9,250,000 3.7 % 246,351 *
ADI Alternative
Investments c/o Axis Pan 1,000,000 * 26,632 *
ADI Alternative
Investments c/o Casam ADI CB Arbitrage 5,000,000 2.0 % 133,163 *
ADI Alternative
Investments c/o Kallista Master Fund Limited 9,250,000 3.7 % 246,351 *
Alcon
Laboratories 465,000 * 12,384 *
Aristeia
International Limited(4) 12,400,000 5.0 % 330,244 *
Aristeia
Partners LP(5) 2,600,000 1.0 % 69,244 *
Arlington County
Employees Retirement System 667,000 * 17,763 *
Bancroft Fund
Ltd. 1,000,000 * 26,632 *
Bank of America
Pension Plan 3,000,000 1.2 % 79,897 *
British Virgin
Islands Social 153,000 * 4,074 *
Canyon Capital
Arbitrage Master Fund, Ltd.(6) 15,810,000 6.3 % 421,061 *
Canyon Value
Realization Fund, L.P.(6) 8,370,000 3.3 % 222,914 *
Canyon Value
Realization MAC 18 Ltd.(6) 930,000 * 24,768 *
CC Arbitrage,
Ltd.(6) 4,000,000 1.6 % 106,530 *
City University
of New York 133,000 * 3,542 *
CQS Convertible
and Quantitative Strategies Master Fund Limited(7) 12,000,000 4.8 % 319,591 *
DBAG London(6)(8) 20,500,000 8.2 % 545,968 *
Ellsworth Fund
Ltd. 1,000,000 * 26,632 *
Equity Overlay
Fund LLC 1,500,000 * 39,948 *
Grady Hospital
Foundation 128,000 * 3,408 *
Highbridge
International LLC 3,000,000 1.2 % 79,897 *
Independence
Blue Cross 860,000 * 22,904 *
JMG Capital
Partners, LP 21,000,000 8.4 % 559,284 *
JMG Triton
Offshore Fund, Ltd.(9) 5,000,000 2.0 % 133,163 *
JPMorgan
Securities Inc.(6) 6,267,000 2.5 % 166,906 *
Merrill Lynch,
Pierce, Fenner & Smith, Inc.(6) 9,833,000 3.9 % 261,878 *
Occidental
Petroleum Corporation 296,000 * 7,883 *
Peoples Benefit
Life Insurance Company Teamsters 2,250,000 * 59,923 *
Plexus Fund
Limited 30,000,000 12.0 % 798,978 *
PNC Equity
Securities LLC(6)(10) 5,000,000 2.0 % 133,163 *
Pro Mutual 841,000 * 22,398 *
Redbourn
Partners LTD 6,000,000 2.4 % 159,795 *
Retail Clerks
Pension Trust #2 1,000,000 * 26,632 *
San Francisco
City and County 1,317,000 * 35,075 *
The Canyon Value
Realization Fund (Cayman), Ltd.(6) 21,390,000 8.6 % 569,671 *
The Grable
Foundation 93,000 * 2,476 *
The Police and
Fire Retirement System of the City of Detroit 631,000 * 16,805 *
Trustmark
Insurance Company 403,000 * 10,732 *
UBS O’Connor LLC
F/B/O O’Connor Global Convertible Arbitrage II Master Ltd.(11) 1,178,000 * 31,373 *
UBS O’Connor LLC
F/B/O O’Connor Global Convertible Arbitrage Master Ltd.(11) 9,822,000 3.9 % 261,585 *
All other holders of
notes or future transferees of such holders(12) 14,663,000 5.9 % 390,513 *

3

SEQ.=1,FOLIO='3',FILE='C:\fc\5312363682_D10496_1748722\5310-1-be.htm',USER='jmsproofassembler',CD='Feb 22 12:36 2007'

* Less than 1%.
(1) The maximum principal amount of notes that may be
sold under this prospectus will not exceed $250,000,000. Assuming all of the
notes are sold under this prospectus, no selling securityholder will
beneficially own any notes upon completion of this offering.
(2) Represents the maximum number of shares of our
common stock issuable upon conversion of all of the holder’s notes based on
the current conversion rate of 26.6326 shares of our common stock per $1,000
principal amount of notes and a cash payment in lieu of any fractional
shares. This conversion rate is subject to adjustment, however, as described
under “Description of Notes—Conversion Rate Adjustments.” As a result, the
maximum number of shares of our common stock issuable upon conversion of the
notes may increase or decrease in the future. To our knowledge, and assuming
all of the shares issuable upon conversion of the notes are sold under this
prospectus, no selling securityholder will beneficially own more than one
percent of our common stock upon completion of this offering.
(3) Calculated based on 135,544,953 shares of our common
stock outstanding as of February 20, 2007. In calculating this amount for
each holder, we treated as outstanding the number of shares of our common
stock issuable upon conversion of all of that holder’s notes, but we did not
assume conversion of any other holder’s notes.
(4) Aristeia Capital LLC is the investment manager for
Aristeia International Limited. Aristeia Capital LLC is jointly owned
by Kevin Toner, Robert H. Lynch, Jr., Anthony Frascella, and William R.
Techar.
(5) Aristeia Advisors LLC is the general partner for
Aristeia Partners LP. Aristeia Advisors LLC is jointly owned by Kevin
Toner, Robert H. Lynch, Jr., Anthony Frascella, and William R. Techar.
(6) The selling securityholder has informed us that it
is, or is an affiliate of, a registered broker-dealer. Each such selling
securityholder has represented to us that it acquired its securities in the
ordinary course of business and, at the time of the acquisition of the
securities, had no agreements or understandings, directly or indirectly, with
any person to distribute the securities. To the extent that we become aware
that any such selling securityholder did not acquire its securities in the
ordinary course of business or did have such an agreement or understanding,
we will file a supplement to this prospectus to designate such selling
securityholder as an “underwriter” within the meaning of the Securities Act
of 1933.
(7) Alan Smith, Blair Gauld, Dennis Hunter, Karla Bodden
and Jim Rogers have the power to direct the voting and disposition of the
securities held by CQS Convertible And Quantitative Strategies Master Fund
Limited.
(8) DBAG London is a subsidiary of Deutsche Bank
Securities Inc., a publicly held entity.
(9) JMG Triton Offshore Fund, Ltd. (the “Fund”) is an
international business company organized under the laws of the British Virgin
Islands. The Fund’s investment manager is Pacific Assets Management LLC, a
Delaware limited liability company (the “Manager”) that has voting and
dispositive power over the Fund’s investments, including the securities
offered hereby. The equity interests of the Manager are owned by Pacific
Capital Management, Inc., a California corporation (“Pacific”) and Asset
Alliance Holding Corp., a Delaware corporation. The equity interests of
Pacific are owned by Messrs. Roger Richter, Jonathan M. Glaser and Daniel A.
David. Messrs. Glaser and Richter have sole investment discretion over the
Fund’s portfolio holdings.
(10) PNC Equity Securities LLC is a subsidiary of PNC
Financial Services Group, a publicly held entity.
(11) UBS O’Connor LLC F/B/O O’Connor Global Convertible
Arbitrage Master Limited and UBS O’Connor LLC F/B/O O’Connor Global
Convertible Arbitrage II Master Ltd. are funds which cede investment control
to UBS O’Connor LLC, which as investment adviser, makes all the investment/voting
decisions. UBS O’Connor LLC is a wholly owned subsidiary of UBS AG, which is
listed and traded on the New York Stock Exchange.
(12) Assumes that any other holder of notes or any future
transferee of any such holder does not beneficially own any common stock
other than the common stock issuable upon conversion of the notes. Additional
selling securityholders not named in this prospectus will be not be able to
use this prospectus for resales until they are named in the selling
securityholder table by prospectus supplement or post-effective amendment.

Information about the selling securityholders may change over time. Any changed information given to us by the selling securityholders will be set forth in prospectus supplements if and when necessary.

4

SEQ.=1,FOLIO='4',FILE='C:\fc\5312363682_D10496_1748722\5310-1-be.htm',USER='jmsproofassembler',CD='Feb 22 12:36 2007'